| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012207447 |
| P356 | DOI | 10.1186/2042-4280-2-3 |
| P932 | PMC publication ID | 3063196 |
| P698 | PubMed publication ID | 21429246 |
| P5875 | ResearchGate publication ID | 50830639 |
| P2093 | author name string | Robert F Kalejta | |
| Rhiannon R Penkert | |||
| P2860 | cites work | An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link | Q21131584 |
| Potential role for luman, the cellular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency | Q22011024 | ||
| Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation | Q22253401 | ||
| Zhangfei: a second cellular protein interacts with herpes simplex virus accessory factor HCF in a manner similar to Luman and VP16. | Q22254354 | ||
| Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1 | Q24296698 | ||
| PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0 | Q24298207 | ||
| Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections | Q24298226 | ||
| The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein | Q24316442 | ||
| The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies | Q24319767 | ||
| Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor | Q24336173 | ||
| Components of the REST/CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells | Q24529064 | ||
| Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies | Q24529499 | ||
| HCF-dependent nuclear import of VP16 | Q24533545 | ||
| Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection | Q24535042 | ||
| Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression | Q24543400 | ||
| Update on human herpesvirus 6 biology, clinical features, and therapy | Q24557543 | ||
| Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation | Q24563478 | ||
| Latency and reactivation of human cytomegalovirus | Q83946800 | ||
| Comprehensive quantification of herpes simplex virus latency at the single-cell level | Q35888505 | ||
| The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency | Q35888512 | ||
| Latent and lytic Epstein-Barr virus replication strategies | Q35896249 | ||
| Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro | Q35901715 | ||
| X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. | Q35914523 | ||
| Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer-binding factor mediates specific induction of virus immediate-early gene expression | Q36000853 | ||
| Modulation of LMP1 protein expression by EBV-encoded microRNAs | Q36092565 | ||
| Herpes simplex virus infections are arrested in Oct-1-deficient cells | Q36159009 | ||
| Towards an understanding of the molecular basis of herpes simplex virus latency | Q36160397 | ||
| Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells | Q36363938 | ||
| Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency | Q36463607 | ||
| Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. | Q36498133 | ||
| Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency | Q36535608 | ||
| Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters | Q36645576 | ||
| Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. | Q36651968 | ||
| The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. | Q36655446 | ||
| Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements | Q36699045 | ||
| A cellular factor binds to the herpes simplex virus type 1 transactivator Vmw65 and is required for Vmw65-dependent protein-DNA complex assembly with Oct-1 | Q36725919 | ||
| The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. | Q36756512 | ||
| Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency | Q36780729 | ||
| During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure | Q36781005 | ||
| Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. | Q36784202 | ||
| Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1 | Q36796909 | ||
| Enhanced infectivity of herpes simplex virus type 1 viral DNA in a cell line expressing the trans-inducing factor Vmw65. | Q36801807 | ||
| A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia | Q36803575 | ||
| An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor | Q36825232 | ||
| Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expression | Q36827546 | ||
| A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency | Q36829179 | ||
| The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. | Q36829427 | ||
| Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. | Q36831483 | ||
| Viral proteomics | Q36842301 | ||
| Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture | Q36885629 | ||
| Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions | Q36888472 | ||
| Herpesviruses and chromosomal integration | Q24610959 | ||
| Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex | Q24675640 | ||
| Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis | Q24816875 | ||
| Reactivation of Epstein-Barr virus from latency | Q27728174 | ||
| Induced alpha helix in the VP16 activation domain upon binding to a human TAF | Q28247311 | ||
| The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro | Q28275318 | ||
| Expression of a large family of POU-domain regulatory genes in mammalian brain development | Q28277007 | ||
| The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1 | Q28298158 | ||
| ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus | Q28471803 | ||
| Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA | Q28474716 | ||
| Early events associated with infection of Epstein-Barr virus infection of primary B-cells | Q28476230 | ||
| Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency | Q28504545 | ||
| Heterochromatin revisited | Q29614716 | ||
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| Transcriptional activators direct histone acetyltransferase complexes to nucleosomes | Q29620509 | ||
| Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain | Q31049140 | ||
| Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus | Q33221784 | ||
| A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication | Q33305011 | ||
| Role of chromatin during herpesvirus infections | Q33346968 | ||
| Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters | Q33422971 | ||
| De novo synthesis of VP16 coordinates the exit from HSV latency in vivo | Q33422983 | ||
| Human cytomegalovirus infection of human hematopoietic progenitor cells | Q33588798 | ||
| Transcriptional coactivator HCF-1 couples the histone chaperone Asf1b to HSV-1 DNA replication components | Q33603879 | ||
| Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection | Q33605277 | ||
| Herpes simplex virus VP16, but not ICP0, is required to reduce histone occupancy and enhance histone acetylation on viral genomes in U2OS osteosarcoma cells. | Q33614347 | ||
| AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome | Q33640163 | ||
| Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle | Q33654414 | ||
| CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp | Q33668727 | ||
| Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells | Q33680515 | ||
| CpG-methylation regulates a class of Epstein-Barr virus promoters | Q33707736 | ||
| Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro | Q33721252 | ||
| Epigenetic regulation of latent HSV-1 gene expression | Q33729340 | ||
| A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components | Q36891387 | ||
| Dynamic histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts | Q36898831 | ||
| Association of the cellular coactivator HCF-1 with the Golgi apparatus in sensory neurons | Q36898912 | ||
| Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters | Q36899046 | ||
| Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells | Q36919210 | ||
| Chromatin control of herpes simplex virus lytic and latent infection | Q37080840 | ||
| Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality | Q37105232 | ||
| Noncoding RNAs produced by oncogenic human herpesviruses | Q37165298 | ||
| Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. | Q37191889 | ||
| Properties of virion transactivator proteins encoded by primate cytomegaloviruses | Q37218898 | ||
| Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia. | Q37275033 | ||
| Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals | Q37313098 | ||
| Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. | Q37329754 | ||
| Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia | Q37365331 | ||
| Drug targets in herpes simplex and Epstein Barr Virus infections | Q37411587 | ||
| During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. | Q37492667 | ||
| Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene | Q37527308 | ||
| Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection | Q37580134 | ||
| The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes | Q37583383 | ||
| Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus | Q37596770 | ||
| The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription | Q37596970 | ||
| Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? | Q37599336 | ||
| Epigenetic regulation of latent Epstein-Barr virus promoters | Q37620765 | ||
| Chromatinisation of herpesvirus genomes. | Q37627720 | ||
| Chromatin dynamics during herpes simplex virus-1 lytic infection | Q37688678 | ||
| Role of EBERs in the pathogenesis of EBV infection | Q37732968 | ||
| Human cytomegalovirus latent infection and associated viral gene expression | Q37762554 | ||
| Chromatin-mediated regulation of cytomegalovirus gene expression. | Q37793472 | ||
| Intrinsic cellular defense mechanisms targeting human cytomegalovirus | Q37799098 | ||
| Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. | Q37879797 | ||
| Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation | Q38347799 | ||
| A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence | Q38347804 | ||
| An inquiry into the mechanisms of herpes simplex virus latency | Q39159400 | ||
| Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo | Q39306039 | ||
| Control of cytomegalovirus lytic gene expression by histone acetylation | Q39646686 | ||
| Cellular Immediate-Early Gene Expression Occurs Kinetically Upstream of Epstein-Barr Virus bzlf1 and brlf1 following Cross-Linking of the B Cell Antigen Receptor in the Akata Burkitt Lymphoma Cell Line | Q39652746 | ||
| Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains | Q39684340 | ||
| Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation | Q39736622 | ||
| Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins | Q39748049 | ||
| Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer | Q39756511 | ||
| Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin. | Q39776571 | ||
| Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus | Q39787577 | ||
| Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production | Q39798154 | ||
| B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression. | Q39837455 | ||
| Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification | Q39852028 | ||
| Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells | Q39860663 | ||
| Plasmid maintenance of derivatives of oriP of Epstein-Barr virus | Q39868910 | ||
| Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. | Q39872953 | ||
| Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. | Q39880945 | ||
| Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection | Q39929078 | ||
| Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells | Q39940813 | ||
| VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection | Q39960651 | ||
| Temporal association of the herpes simplex virus genome with histone proteins during a lytic infection | Q40030721 | ||
| Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence. | Q40045269 | ||
| Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter | Q40075775 | ||
| Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. | Q40109691 | ||
| Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro | Q40114561 | ||
| Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells | Q40115653 | ||
| Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes | Q40213284 | ||
| Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter | Q40221207 | ||
| Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line | Q40228925 | ||
| Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. | Q40274387 | ||
| Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication | Q40416407 | ||
| The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome | Q40516561 | ||
| Characterization of a cellular factor which interacts functionally with Oct-1 in the assembly of a multicomponent transcription complex | Q40526875 | ||
| Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells | Q40756627 | ||
| Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos | Q40816920 | ||
| Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. | Q40898224 | ||
| Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types | Q40965293 | ||
| Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. | Q41007964 | ||
| Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product | Q41039727 | ||
| The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells | Q41112391 | ||
| Immature and Transitional B Cells Are Latency Reservoirs for a Gammaherpesvirus | Q41232435 | ||
| Quiescent viral genomes in human fibroblasts after infection with herpes simplex virus type 1 Vmw65 mutants | Q41337703 | ||
| Human cytomegalovirus protein pp71 induces Daxx SUMOylation | Q41360318 | ||
| Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity | Q41587905 | ||
| Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. | Q41627244 | ||
| Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. | Q41711280 | ||
| Chromatin profiling of Epstein-Barr virus latency control region | Q41867337 | ||
| Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection | Q41913861 | ||
| Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitro | Q42043652 | ||
| Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. | Q42063435 | ||
| Nuclear Localization of Tegument-Delivered pp71 in Human Cytomegalovirus-Infected Cells Is Facilitated by One or More Factors Present in Terminally Differentiated Fibroblasts | Q42428110 | ||
| Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. | Q42502083 | ||
| The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. | Q42673928 | ||
| Essential elements of a licensed, mammalian plasmid origin of DNA synthesis. | Q42678529 | ||
| Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency | Q43130211 | ||
| Synchronous appearance of antigen-positive and latently infected neurons in spinal ganglia of mice infected with a virulent strain of herpes simplex virus | Q43673524 | ||
| Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors | Q43769307 | ||
| Integration of human herpesvirus 6 genome in human chromosomes | Q43782358 | ||
| Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic 'pre-immediate-early' repression of viral gene expression mediated by histone post-translational modification | Q44114064 | ||
| Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression | Q44124969 | ||
| Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter | Q44333555 | ||
| An analysis of herpes simplex virus gene expression during latency establishment and reactivation | Q44879649 | ||
| Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome | Q44946017 | ||
| The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. | Q45381898 | ||
| Establishment of a quiescent herpes simplex virus type 1 infection in neurally-differentiated PC12 cells. | Q45748278 | ||
| Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product | Q45752869 | ||
| Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts | Q45775176 | ||
| BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes | Q45787415 | ||
| Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines | Q45797211 | ||
| The Structure of Herpes Simplex Virus Type 1 DNA as Probed by Micrococcal Nuclease Digestion | Q45802614 | ||
| Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. | Q45835577 | ||
| An in vitro latency system for herpes simplex virus type 2. | Q45837412 | ||
| TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation | Q45842007 | ||
| Epstein-Barr virus infection and replication in a human epithelial cell system | Q45880200 | ||
| Herpes simplex viral infection of the mouse trigeminal ganglion. Immunohistochemical analysis of cell populations | Q46239823 | ||
| The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. | Q47356708 | ||
| Genetic content of wild-type human cytomegalovirus | Q47709383 | ||
| Sequential recruitment of HAT and SWI/SNF components to condensed chromatin by VP16. | Q51839498 | ||
| Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. | Q53914767 | ||
| Reduced binding of TFIID to transcriptionally compromised mutants of VP16. | Q54251780 | ||
| Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells | Q57076525 | ||
| Characterization of Physical Interactions of the Putative Transcriptional Adaptor, ADA2, with Acidic Activation Domains and TATA-binding Protein | Q58130306 | ||
| Binding of general transcription factor TFIIB to an acidic activating region | Q59058683 | ||
| RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons | Q68986775 | ||
| Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors | Q72988509 | ||
| Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays | Q73151282 | ||
| The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems | Q77865759 | ||
| An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling | Q81355877 | ||
| Latent infection of human herpesvirus 7 in CD4(+) T lymphocytes | Q81507982 | ||
| Noncytotoxic inhibition of cytomegalovirus replication through NK cell protease granzyme M-mediated cleavage of viral phosphoprotein 71 | Q82363560 | ||
| Antiviral treatment of cytomegalovirus infection and resistant strains | Q83390206 | ||
| Chromatin organization of gammaherpesvirus latent genomes | Q33729584 | ||
| EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3 | Q33793531 | ||
| Analysis of HCF, the cellular cofactor of VP16, in herpes simplex virus-infected cells | Q33794386 | ||
| Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. | Q33794645 | ||
| Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency | Q33796650 | ||
| Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. | Q33826615 | ||
| ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency | Q33838198 | ||
| Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents | Q33840193 | ||
| Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent | Q33852869 | ||
| Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. | Q33864322 | ||
| A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones | Q33910593 | ||
| Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. | Q33921258 | ||
| Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency | Q33931502 | ||
| Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers | Q33932471 | ||
| Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates | Q33960598 | ||
| Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. | Q33964039 | ||
| Epstein-Barr virus infection | Q34004958 | ||
| Viral latency and its regulation: lessons from the gamma-herpesviruses | Q34039189 | ||
| Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells | Q34055456 | ||
| The expression and function of Epstein-Barr virus encoded latent genes | Q34089485 | ||
| Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model | Q34123985 | ||
| Latency and reactivation of human cytomegalovirus | Q34134374 | ||
| Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model | Q34156527 | ||
| The herpes simplex virus VP16-induced complex: the makings of a regulatory switch | Q34208918 | ||
| Molecular virology of Epstein-Barr virus | Q34225554 | ||
| Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency | Q34232948 | ||
| Coding potential of laboratory and clinical strains of human cytomegalovirus | Q34388908 | ||
| Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency | Q34415946 | ||
| A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas | Q34457976 | ||
| ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus | Q34461528 | ||
| The neuronal host cell factor-binding protein Zhangfei inhibits herpes simplex virus replication | Q34466767 | ||
| Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression | Q34555693 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs | Q34593731 | ||
| Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells | Q34598541 | ||
| Prediction and identification of herpes simplex virus 1-encoded microRNAs | Q34648394 | ||
| Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42. | Q34717579 | ||
| Human cytomegalovirus: Latency and reactivation in the myeloid lineage | Q34731399 | ||
| The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis | Q34812044 | ||
| Transcription of the herpes simplex virus latency-associated transcript promotes the formation of facultative heterochromatin on lytic promoters | Q34986080 | ||
| Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes | Q35101353 | ||
| A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. | Q35542971 | ||
| B cells under influence: transformation of B cells by Epstein–Barr virus | Q35549146 | ||
| The BCL-2 family reunion | Q35568029 | ||
| Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. | Q35635326 | ||
| UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells | Q35847129 | ||
| Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency | Q35881137 | ||
| Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle | Q35886438 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3 | |
| P577 | publication date | 2011-02-08 | |
| P1433 | published in | Herpesviridae | Q27723516 |
| P1476 | title | Tegument protein control of latent herpesvirus establishment and animation | |
| P478 | volume | 2 |
| Q26996418 | A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation |
| Q27015883 | A cultured affair: HSV latency and reactivation in neurons |
| Q35652716 | An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons |
| Q35317749 | Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients |
| Q30519179 | BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection |
| Q27335160 | Cellular defense against latent colonization foiled by human cytomegalovirus UL138 protein |
| Q45350755 | Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal. |
| Q47599407 | Compartmented neuronal cultures reveal two distinct mechanisms for alpha herpesvirus escape from genome silencing. |
| Q59359836 | Cytomegalovirus: Shape-Shifting the Immune System |
| Q47792353 | Development of a quantitative PCR assay for measurement of trichechid herpesvirus 1 load in the Florida manatee ( Trichechus manatus latirostris). |
| Q34270399 | Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection |
| Q36434206 | Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase |
| Q28074586 | Epstein-Barr Virus: Diseases Linked to Infection and Transformation |
| Q90748167 | Expanding the Known Functional Repertoire of the Human Cytomegalovirus pp71 Protein |
| Q35843000 | First molecular determination of herpesvirus from two mysticete species stranded in the Mediterranean Sea |
| Q39130826 | Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency |
| Q90722837 | Hinge Region in DNA Packaging Terminase pUL15 of Herpes Simplex Virus: A Potential Allosteric Target for Antiviral Drugs |
| Q92225749 | Human Cytomegalovirus Enters the Primary CD34+ Hematopoietic Progenitor Cells Where It Establishes Latency by Macropinocytosis |
| Q59360165 | Human Cytomegalovirus Productively Replicates in Undifferentiated Oral Epithelial Cells |
| Q30570561 | Human cytomegalovirus major immediate early 1 protein targets host chromosomes by docking to the acidic pocket on the nucleosome surface |
| Q39046934 | Insertion of myeloid-active elements into the human cytomegalovirus major immediate early promoter is not sufficient to drive its activation upon infection of undifferentiated myeloid cells |
| Q36205880 | Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice |
| Q89395084 | Latent versus productive infection: the alpha herpesvirus switch |
| Q59357897 | Molecular Aspects of Varicella-Zoster Virus Latency |
| Q37123492 | Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations |
| Q30689513 | Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation |
| Q39404887 | Recombinant cell lines expressing shRNA targeting herpes simplex virus 2 VP16 inhibit virus replication |
| Q38078937 | Tale of a tegument transactivator: the past, present and future of human CMV pp71 |
| Q47283029 | The loss of binary: Pushing the herpesvirus latency paradigm |
| Q34916815 | Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection |
| Q28576674 | Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons |
| Q34594789 | Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection. |
Search more.